Mitosin, a novel marker of cell proliferation and early recurrence in intracranial meningiomas

Histology and Histopathology

Volumn 18, Issue 1, 2003, Pages 67-74

  Konstantinidou, A E ^a   Korkolopoulou, P ^a   Kavantzas, N ^a   Mahera, H ^b   Thymara, I ^a   Kotsiakis, X ^c   Perdiki, M ^a   Patsouris, E ^a   Davaris, P ^a  

^a UNIVERSITY OF ATHENS   (Greece)

^b KAT HOSPITAL   (Greece)

^c General Hospital of Hania   (Greece)

Author keywords

Meningiomas; Mitosin; Proliferation; Recurrence; Survival

Indexed keywords

BIOLOGICAL MARKER; CYCLINE; DNA TOPOISOMERASE (ATP HYDROLYSING); DNA TOPOISOMERASE (ATP HYDROLYSING) ALPHA; KI 67 ANTIGEN; MITOSIN; PHOSPHOPROTEIN; UNCLASSIFIED DRUG;

ARTICLE; BRAIN TUMOR; CANCER INCIDENCE; CANCER SURGERY; CANCER SURVIVAL; CELL PROLIFERATION; CLINICAL ARTICLE; CONTROLLED STUDY; CORRELATION ANALYSIS; FACTORIAL ANALYSIS; FOLLOW UP; HUMAN; IMMUNOHISTOCHEMISTRY; LABELING INDEX; MALIGNANT MENINGIOMA; MALIGNANT NEOPLASTIC DISEASE; MENINGIOMA; MITOSIS INDEX; MULTIVARIATE ANALYSIS; PATHOLOGY; PREDICTION; PROGNOSIS; PROTEIN EXPRESSION; STATISTICAL ANALYSIS; TREATMENT OUTCOME; TUMOR RECURRENCE; TUMOR VOLUME;

ANTIGENS, NEOPLASM; CELL DIVISION; CHROMOSOMAL PROTEINS, NON-HISTONE; DNA TOPOISOMERASES, TYPE II, EUKARYOTIC; DNA-BINDING PROTEINS; HUMANS; IMMUNOHISTOCHEMISTRY; KI-67 ANTIGEN; MENINGEAL NEOPLASMS; MENINGIOMA; MICROFILAMENT PROTEINS; NEOPLASM RECURRENCE, LOCAL; PROLIFERATING CELL NUCLEAR ANTIGEN; SURVIVAL ANALYSIS; TUMOR MARKERS, BIOLOGICAL;

EID: 0037214820     PISSN: 02133911     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (32)

1. Bookwalter, J.W. III, Sekler RG., Schiffer L., Randall M., Iannuzzi D. and Kristofik B.S. (1986). Brain-tumor cell kinetics correlated with survival. J. Neurosurg. 65, 795-798.
2. Christensen E., Laursen H. and Klinken L. (1983). Prediction of recurrence in meningiomas after surgical treatment. A quantitative approach. Acta Neuropathol. 61, 130-134.
3. Clark G.M., Allred C.D., Hilsenbeck S.G., Chamness G.C., Osborne C.K., Jones D. and Lee W-H. (1997). Mitosin (a new proliferation marker) correlates with clinical outcome in node-negative breast cancer. Cancer Res. 57, 5505-5508.
4. Cobb M.A., Husain M., Andersen B.J. and Al-Mefty O. (1996). Significance of proliferating cell nuclear antigen in predicting recurrence of intracranial meningioma. J. Neurosurg. 84, 85-90.
5. Von Deimling A., Larson J., Wellenreuther R., Stangl A.P., Van Velthove V., Warnick R., Tew J. Jr, Balko G. and Menon A.G. (1999). Clonal origin of recurrent meningiomas. Brain Pathol. 9, 645-650.
6. Holt P.R., Moss S.F., Kapetanakis A.M., Petratos A. and Wang S. (1997). Is Ki-67 a better proliferative marker in the colon than proliferating cell nuclear antigen? Cancer Epidemiol. Biomarkers Prev. 6, 131-135.
7. Hoshino T. and Wilson C.B. (1975). Review of basic concepts of cell kinetics as applied to brain tumors. J. Neurosurg. 42, 123-131.
8. Hoshino T., Rodriguez L.A., Cho KG., Lee K.S., Wilson C.B., Edwards M.S.B., Levin V.A., Davis R.L. (1988). Prognostic implications of the proliferative potential of low-grade astrocytomas. J. Neurosurg. 69, 839-842.
9. Hsu D.W., Pardo F.S., Efird J.T., Linggood R.M. and Hedley-Whyte E.T. (1994). Prognostic significance of proliferative indices in meningiomas. J. Neuropathol. Exp. Neurol. 53, 247-255.
10. Hsu D.W., Efird J.T. and Hedley-Whyte E.T. (1998). MIB-1 (Ki-67) index and transforming growth factor-alpha (TGF alpha) immunoreactivity are significant prognostic predictors for meningiomas. Neuropathol. Appl. Neurobiol. 24, 441-452.
11. Jääskeläinen J., Haltia M., Lääsonen E., Wahlstrum T. and Valtonen S. (1985). The growth rate of intracranial meningiomas and its relation to histology. Surg. Neurol. 24, 165-271.
12. Kakinuma K., Tanaka R., Onda K. and Takahashi H. (1998). Proliferative potential of recurrent intracranial meningiomas as evaluated by labeling indices of BudR and Ki-67, and tumor doubling time. Acta Neurochir. (Wien) 140, 26-31.
13. Karamitopoulou E., Perentes E., Tolnay M. and Probst A. (1998). Prognostic significance of MIB-1, p53 and bcl-2 immunoreactivity in meningiomas. Hum. Pathol. 29, 140-145.
14. Kersting G. and Lennartz H. (1957). In vitro cultures of human meningioma tissue. J. Neuropathol. Exp. Neurol. 16, 507-513.
15. Khoshyomn S., Maier H., Morimura T., Kitz K. and Budka H. (1993). Immunostaining for proliferative cell nuclear antigen: Its role in determination of proliferation in routinely processed human brain tumor specimens. Acta Neuropathol. Berl. 86, 582-589.
16. Konstantinidou A.E., Pavlopoulos P.M., Patsouris E., Kaklamanis L. and Davaris P. (1998). Expression of apoptotic and proliferation markers in meningiomas. J. Pathol. 186, 325-330.
17. Konstantinidou A.E., Patsouris E., Korkolopoulou P., Kavantzas N., Mahera H. and Davaris P. (2001). DNA topoisomerase IIα expression correlates with cell proliferation but not with recurrence in intracranial meningiomas. Histopathology 39, 402-408.
18. Korkolopoulou P, Patsouris E., Konstantinidou A.E., Christodoulou P., Thomas-Tsagli E., Kouzelis K., Angelidakis D., Rologis D. and Davaris P. (2001). Mitosin and DNA Topoisomerase IIα: Two novel proliferation markers in the prognostication of diffuse astrocytoma patient survival. Appl. Immunohistochem. Mol. Morphol. 9, 207-214.
19. Louis D.N., Edgerton S., Thor A.D. and Hedley-Whyte E.T. (1991). Proliferating cell nuclear antigen and Ki-67 immunohistochemistry in brain tumors: A comparative study. Acta Neuropathol. 81, 675-679.
20. Louis D.N., Scheithauer B.W., Budka H., Von Deimling A. and Kepes J.J. (2000). Meningiomas. In: Pathology and Genetics of Tumours of the Nervous System. 2nd ed. Kleihues P. and Cavenee W.K. (eds). International Agency for Research. Lyon. pp. 176-184.
21. Lumsden C.E. (1971). The study of tissue cultures of tumors of the nervous system. Russell D.S. and Rubinstein L.J. (eds). Williams & Wilkins. Baltimore. In: Pathology of Tumours of the Nervous System, 3rd ed. pp 383-386.
22. McCormick D. and Hall P.A. (1992). The complexities of proliferating cell nuclear antigen. Histopathology 21, 591-594.
23. Mirimanoff R.O., Dosoretz D.E., Linggood R.M., Ojeman R.G., Martuza R.L. (1985). Meningioma: Analysis of recurrence and progression following neurosurgical resection. J. Neurosurg. 62, 18-24.
24. Munakata S. and Hendricks J.B. (1993). Effect of fixation time and microwave-oven heating time on retrieval of the Ki-67 antigen from paraffin-embedded tissue. J. Histochem. Cytochem. 41, 1241-1246.
25. Nakasu S., Nakajima M., Matsumura K., Nakasu Y. and Handa J. (1995). Meningiomas: Proliferating potential and clinicopathological features. Neurosurgery 37, 1049-1055.
26. Du Plessis D.G., Yusoff S., Roebuck M.M., Gledhill P.J., Rossi M.L. and Broome J.C. (2000) An analysis of histopathological features associated with early recurrence in meningiomas. Brain Pathol. 10, 742 (Abstract).
27. Rosenblum M.L., Vasquez D.A., Hoshino T. and Wilson C.B. (1978). Development of a clonogenic cell assay for human brain tumors. Cancer 41, 2305-2314.
28. Simpson D. (1957). The recurrence of intracranial meningiomas after surgical treatment. J. Neurol. Neurosurg. Psychiatry 20, 22-39.
29. Tanaka M., Kubo O., Tajika Y., Takahashi T., Suzuki S. and Takakura K. (1999). Immunohistochemical evaluation of intracranial recurrent meningiomas correlation of topoisomerase II alpha expression and cell proliferative potential. No To Shinkei 51, 1033-1039.
30. Taniguchi K., Wakabayashi T., Yoshida T., Mizuno M., Yoshikawa K., Kikuchi A., Nakashima N. and Yoshida J. (1999). Immunohistochemical staining of DNA topoisomerase IIα in human gliomas. J. Neurosurg. 91, 477-482.
31. Zhu X., Mancini M.A., Chang K.H., Liu C.Y., Chen C.F., Shan B., Jones D., Yang-Feng T.L. and Lee W.H. (1995). Characterization of a novel 350-kilodalton nuclear phosphoprotein that is specifically involved in mitoticphase progression. Mol. Cell Biol. 15, 5017-5029.
32. Zhu X., Chang K.H., He D., Mancini M.A., Brinkley W.R. and Lee W.H. (1995). The C-terminus of mitosin is essential for its nuclear localization, centromere/ cinetochore targeting, and dimerization. J. Biol. Chem. 270, 19545-19550.